Market research
4574.TSE Taiko Pharmaceutical Co.,Ltd
TSE JPY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 13B
- P/E ratio
- 19.22
- Analyst target
- 3300
- Dividend yield
- 1.3%
- Beta
- 0.32
Community
Investor discussion
1 comment
Sign in to join the 4574.TSE discussion.
5 years, 6 months ago
Taiko Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 34.0% below its 200 day moving average.
From a valuation standpoint, the stock is 96.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Taiko Pharmaceutical Co.,Ltd's total revenue sank by 8.8% to $5B since the same quarter in the previous year.
Its net income has dropped by 33.5% to $988M since the same quarter in the previous year.
Based on the above factors, Taiko Pharmaceutical Co.,Ltd gets an overall score of 1/5.